Comprehensive Insights into Hypertension: Pathophysiology and Management

Abstract

Hypertension is a significant risk factor for cardiovascular diseases, often coexisting with other metabolic abnormalities. Systolic blood pressure plays a critical role in determining cardiovascular risk, particularly in older populations. Essential hypertension, accounting for approximately 95% of cases, lacks a clearly identifiable cause despite extensive research. Globally, the incidence of hypertension continues to rise, with long-term treatment frequently falling short of achieving sustained blood pressure control. Epidemiological studies highlight the high prevalence of hypertension worldwide, with varying rates of awareness, treatment, and control across regions. Racial and ethnic disparities in hypertension prevalence have also been observed. The pathophysiology of essential hypertension involves complex interactions between genetic predispositions, sympathetic nervous system overactivity, renal mechanisms, vascular endothelial dysfunction, and hormonal factors such as the renin-angiotensin-aldosterone system. Obesity, obstructive sleep apnea, and insulin resistance are also significant contributors to hypertension development. Accurate blood pressure measurement is crucial for diagnosis, with out-of-office monitoring methods providing valuable information. Treatment primarily aims to prevent critical complications and should be tailored to individual needs. Lifestyle modifications, including weight reduction, physical activity, smoking cessation, and dietary changes, are recommended for all individuals with confirmed hypertension. When lifestyle changes fail to achieve target blood pressure goals, pharmacological therapy becomes necessary. Various classes of antihypertensive drugs, such as diuretics, calcium channel blockers, ACE inhibitors, and ARBs, are available, each with unique mechanisms of action and side effect profiles. The selection of appropriate antihypertensive agents should consider factors such as age, comorbidities, and patient-specific characteristics to optimize treatment outcomes and minimize adverse effects.